The Oxford-AstraZeneca vaccine is also being tested among Indian volunteers as part of global phase 3 trials in different populations.(REUTERS)
The Oxford-AstraZeneca vaccine is also being tested among Indian volunteers as part of global phase 3 trials in different populations.(REUTERS)

SII to seek emergency licence in two weeks

The announcement comes at the end of a week when Oxford and AstraZeneca announced their vaccine had shown to be at least 62% (and up to 90%) effective in an interim analysis based on 131 infections in the clinical trials being held in the United Kingdom and Brazil.
By Rhythma Kaul and Saubhadra Chatterji | Hindustan Times, New Delhi
UPDATED ON NOV 29, 2020 05:30 AM IST

The Serum Institute of India (SII) will apply for an emergency approval for the coronavirus vaccine developed by University of Oxford and AstraZeneca in two weeks, its chief executive Adar Poonawalla said on Saturday, hours after meeting Prime Minister Narendra Modi who was on a three-city tour to pharma companies working on an inoculation against the Sars-Cov-2.

The announcement comes at the end of a week when Oxford and AstraZeneca announced their vaccine had shown to be at least 62% (and up to 90%) effective in an interim analysis based on 131 infections in the clinical trials being held in the United Kingdom and Brazil.

“We are in the process of applying to India’s drugs regulator-- the drugs controller general of India (DCGI) -- in next two weeks for emergency licensure and things will follow then in that order. We are in the process of submitting data to DCGI for analysis,” said Poonawalla.

“Had a good interaction with the team at Serum Institute of India. They shared details about their progress so far on how they plan to further ramp up vaccine manufacturing. Also took a look at their manufacturing facility,” Prime Minister Modi said in a tweet after visiting the Pune facility where he met Poonawalla.

Earlier, Modi visited the vaccine manufacturing unit of Zydus Cadila in Ahmedabad and of Bharat Biotech in Hyderabad. Both the companies have developed their own vaccine candidates that are into advanced stages of clinical trials.

“The central message of this trip is to motivate the vaccine producers. Here is a PM sitting down with promoters, chief scientists to discuss the details of their work. Even though he couldn’t give more than half an hour at each facility as he had to travel between different cities, he was not short of enthusiasm. Never before has any PM gone to such facilities to discuss their work in detail,” said a government official who asked not to be named.

The Oxford-AstraZeneca vaccine candidate is among the global front-runners in terms of volumes produced and clinical trial progress, and is being closely watched because it is cheaper and easier to transport than its only rivals that have shown efficacy till now: the mRNA vaccines by Moderna and Pzifer-BioNTech. All of these vaccines have a two-dose regimen.

The Oxford-AstraZeneca vaccine is also being tested among Indian volunteers as part of global phase 3 trials in different populations.

Experts said the approval process would depend on what data SII approaches the national drugs regulator with. “We need to be sure about which data they will be providing -- only Indian component of global [trial]? Only 2 full-dose component or also include the half-full stream as well,” said Dr K Srinath Reddy, founder, Public Health Foundation of India.

The dose references relate to the difference in efficacy in the announcement by Oxford and AstraZeneca. The developers found that the vaccine was more effective among people who were given a half-strength first dose, a regimen that was not originally planned, leading many experts to question the scientific sanctity of the trials.

Poonawalla said the controversy will not affect the trials in India. “At the moment trials are enough to establish the efficacy. In future, if at all we have to conduct fresh trials it will be for under 18 age group after safety is established in adults,” he added.

The lower efficacy with two full doses, while not as good as the 95% reported by Moderna and Pfizer, could be enough for an approval by regulators since they have set the bar at 50%. The British pharma company’s CEO told Bloomberg on Thursday that the company may undertake a new trial with the half-strength dose.

Poonawalla, in his comments on the opening day of the 18th Hindustan Times Leadership Summit this month, indicated that an emergency use licence could be secured by January.

The PM’s discussion with the SII team largely centred around the vaccine implementation plan, and the pros and cons of all Covid-19 vaccine candidates in the fray, as well as estimates of doses that will need to be made available.

“The indication is for about 300-400 million doses by July 2021, which the government has earlier also announced on various occasions. We are trying to get to the target. The government will have to take a balanced view keeping in mind pros and cons of all the vaccines out there,” Poonawalla added on Saturday.

SII has manufactured about 40 million doses of the vaccine and can currently make about 50-60 million a month, with the capacity expected to be scaled up to 100 million by February. “How to distribute and where to distribute -- all this was discussed. We have indicated a price which is affordable and accessible for everybody but it all depends on regulatory approvals. However, stockpiling and manufacturing is continuing as it is and even if there is delay in getting approvals there shouldn’t be any delays in producing volumes,” said Poonawalla.

As per results available currently, the vaccine has shown zero hospitalisation in patients and the viral load reduced by about 60%, said the SII CEO. “It means that even if you get hospitalised, the attack won’t be severe; and those who are infected won’t transmit, which is bonus for a vaccine for a disease that is so infective,” he said.

SII has a licence to produce a billion doses of the vaccine for low- and middle-income countries, and has committed to reserve half of what it produces for India.

Officials aware of the PM’s plans said the visit was meant to motivate the scientists and the employees of these firms. “Visited the Zydus Biotech Park in Ahmedabad to know more about the indigenous DNA based vaccine being developed by Zydus Cadila. I compliment the team behind this effort for their work. Government of India is actively working with them to support them in this journey. At the Bharat Biotech facility in Hyderabad, was briefed about their indigenous Covid-19 vaccine. Congratulated the scientists for their progress in the trials so far...,” Modi said in two tweets after the visits, each of which lasted around 20-25 minutes and involved hectic flights and helicopter transports.

According to an official who asked not to be named, the PM met the promoters of the companies and the chief scientists. At each of the facilities, the PM sought to know how they are conducting the trials, the status of vaccine development and, apart from Covid vaccine research, what other activities related to drugs or diagnostics are undertaken at each place.

SHARE THIS ARTICLE ON
app
Close
App-based cab driver Vijay N says fuel prices should be brought down.( Satish Bate/HT )
App-based cab driver Vijay N says fuel prices should be brought down.( Satish Bate/HT )

‘Want emergency fund, insurance for cabbies’: Vijay N

By HT Correspondent, Mumbai
PUBLISHED ON JAN 19, 2021 02:28 AM IST
For the 2021 Union budget, Vijay N wants the government to create an emergency fund for drivers and provide insurance to cab drivers. “Drivers who have been operating for six months and do not have any accident on record should be provided with an emergency fund facility,” he said.
Close
As a matter of principle, said the bench, the apex court should not interfere when there are concurrent findings by all the subordinate courts.(PTI)
As a matter of principle, said the bench, the apex court should not interfere when there are concurrent findings by all the subordinate courts.(PTI)

‘50% of our orders will be reversed by a higher court’: SC cautions on appeals

By Utkarsh Anand, New Delhi
PUBLISHED ON JAN 19, 2021 02:19 AM IST
Justice Sanjay K Kaul, heading a three-judge-bench, made this avowal while asserting that there has to be an end to appeals against every order passed by subordinate courts. The bench also included justices Dinesh Maheshwari and Hrishikesh Roy.
Close
A further eight states reported fewer than 100 new infections(Sunil Ghosh /HT Photo)
A further eight states reported fewer than 100 new infections(Sunil Ghosh /HT Photo)

India's daily tally of new Covid cases less than 10,000 first time since June 9

By HT Correspondent, New Delhi
UPDATED ON JAN 19, 2021 02:09 AM IST
While these numbers correspond to tests done on a Sunday, when less testing is done, they underscore the trend that the outbreak has been receding.
Close
The unions are planning a rally on January 26 comprising tens of thousands of farmers to push for the repeal of the three laws.(PTI)
The unions are planning a rally on January 26 comprising tens of thousands of farmers to push for the repeal of the three laws.(PTI)

Farmers' protest: SC refuses to step in on Republic Day tractor rally

By Utkarsh Anand, Abraham Thomas, New Delhi
UPDATED ON JAN 19, 2021 02:03 AM IST
Declining to pass any order on a plea by Delhi Police, a bench headed by Chief Justice of India (CJI) SA Bobde said it was not for the court to remind the authorities of their policing power by passing an order.
Close
India is administering two vaccines as part of the first phase of Covid-19 immunisation covering roughly 30 million health care and other frontline workers.(AFP)
India is administering two vaccines as part of the first phase of Covid-19 immunisation covering roughly 30 million health care and other frontline workers.(AFP)

580 adverse events reported in three days of vaccination

By Rhythma Kaul, New Delhi
PUBLISHED ON JAN 19, 2021 01:52 AM IST
“So far, cumulative 580 AEFI have been reported, of which seven needed hospitalisation,” said Manohar Agnani, additional secretary, Union health ministry.
Close
The government said that between Saturday morning and 5pm on Monday, 381,305 people were given doses in 7,704 sessions.(ANI)
The government said that between Saturday morning and 5pm on Monday, 381,305 people were given doses in 7,704 sessions.(ANI)

Covid-19 vaccination drive hit by hesitancy hurdle

By Rhythma Kaul, Anonna Dutt, New Delhi
PUBLISHED ON JAN 19, 2021 01:39 AM IST
The turnout dipped from 4,319 on Saturday to 3,593 on Monday in the national capital. At AIIMS in Delhi, only eight people were vaccinated on Monday, an official said, while asking not to be named. Officials said concerns over the vaccines’ safety appear to have deterred many people.
Close
Maharashtra Home Minister Anil Deshmukh will meet senior officials of his department to decide on a future course of action.(HT PHOTO)
Maharashtra Home Minister Anil Deshmukh will meet senior officials of his department to decide on a future course of action.(HT PHOTO)

Probe purported chats between Arnab Goswami and Partho Dasgupta: MVA partners

PUBLISHED ON JAN 19, 2021 12:32 AM IST
  • The NCP demanded a joint parliamentary committee probe into the leaked WhatsApp chats, the Congress sought a probe under the Official Secrets Act and the Shiv Sena said demanded action against Arnab Goswami for breach of internal security.
Close
Deputy chief minister and NCP leader Ajit Pawar said, “The voters voted in favour of the MVA. Ruling parties fought in cooperation and it resulted in the combined victory."(HT File Photo)
Deputy chief minister and NCP leader Ajit Pawar said, “The voters voted in favour of the MVA. Ruling parties fought in cooperation and it resulted in the combined victory."(HT File Photo)

MVA gains, but BJP may emerge as largest party in Maha panchayat polls

PUBLISHED ON JAN 19, 2021 12:27 AM IST
The BJP won about 2,600 gram panchayats, followed by the Sena, which won 2,570 of the 11,800 panchayats whose results were declared late on Monday evening. The NCP and Congress bagged 2,400 and 1,825 panchayats respectively, while local panels and independents won over 2,335 panchayats.
Close
Union health minister Harsh Vardhan displays a vial of Bharat Biotech Ltd. Covaxin at the All India Institute of Medical Sciences in New Delhi.(Bloomberg Photo )
Union health minister Harsh Vardhan displays a vial of Bharat Biotech Ltd. Covaxin at the All India Institute of Medical Sciences in New Delhi.(Bloomberg Photo )

Govt assesses supply of Covid-19 vaccines to neighbours, developing countries

By HT Correspondent, New Delhi
UPDATED ON JAN 19, 2021 12:18 AM IST
  • Several countries have either signed agreements or are in talks with Serum Institute or Bharat Biotech, including Bangladesh, Brazil, Saudi Arabia, South Africa and Morocco.
Close
Image for representation.(Unsplash)
Image for representation.(Unsplash)

Travel portals expecting better year; long-weekends likely to provide traction

By HT Correspondent, Mumbai
UPDATED ON JAN 19, 2021 12:03 AM IST
  • Long weekends around Republic Day, Good Friday, Holi, Janmashtami, Dussehra and Christmas are expected to see significant interest from travellers.
Close
File photo: NIA logo.(ANI)
File photo: NIA logo.(ANI)

In probe against Khalistanis, NIA examines people linked to farmers’ protests

PUBLISHED ON JAN 18, 2021 11:57 PM IST
  • NIA officials said that most of the people who appeared before the agency in the last few days, have been examined as “witnesses”.
Close
Kashmir has been in the grip of a severe cold wave this season.(HT FIEL PHOTO)
Kashmir has been in the grip of a severe cold wave this season.(HT FIEL PHOTO)

Cold wave claims lives of two nomad children in Kashmir

PUBLISHED ON JAN 18, 2021 11:05 PM IST
  • The family of nomads had been living in a ramshackle shed covered with tarpaulin and polythene in a forest area of Devsar in Kulgam district.
Close
Farmers are seen sitting during an ongoing protest against the new farm laws at the Singhu border near New Delhi on Monday. (ANI Photo)
Farmers are seen sitting during an ongoing protest against the new farm laws at the Singhu border near New Delhi on Monday. (ANI Photo)

Govt postpones 10th round of talks with farmers' leaders to Jan 20: Reports

By hindustantimes.com | Edited by Meenakshi Ray, New Delhi
UPDATED ON JAN 18, 2021 11:01 PM IST
The farmers have been protesting since November last year to demand the scrapping of farm laws saying they will hurt their livelihoods.
Close
A medic administers the dose of Covishield vaccine to senior doctor of IGIMS hospital, in Patna on Monday. (ANI)
A medic administers the dose of Covishield vaccine to senior doctor of IGIMS hospital, in Patna on Monday. (ANI)

Glitches in Co-WIN portal leads to drop in Covid vaccination percentage in Bihar

PUBLISHED ON JAN 18, 2021 10:44 PM IST
  • Vaccination officers complained that the Co-WIN portal was slow in responding that made uploading information on it time consuming and tedious.
Close
Dravida Munnetra Kazhagam (DMK) party president M.K. Stalin.(AP)
Dravida Munnetra Kazhagam (DMK) party president M.K. Stalin.(AP)

Stalin accuses AIADMK govt of putting on hold projects brought during DMK rule

PTI
PUBLISHED ON JAN 18, 2021 10:41 PM IST
Stalin claimed the DMK government had completed 80 per cent of the work on the Hogenakkal integrated drinking water project.
Close
SHARE
Story Saved
OPEN APP